Cargando…
Comparison of quality of human serum albumin preparations in two pharmaceutical products
AIM: Human serum albumin (HSA) is known for its multiple functions, such as maintenance of colloid osmotic pressure, transport of endogenous and exogenous substances, and antioxidation. The aim of this study was to measure the redox state and concentrations of β‐d‐glucan and endotoxin to compare the...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674470/ https://www.ncbi.nlm.nih.gov/pubmed/29123871 http://dx.doi.org/10.1002/ams2.259 |
_version_ | 1783276780152422400 |
---|---|
author | Nakae, Hajime Tomida, Kouki Kikuya, Yoshihiro Okuyama, Manabu Igarashi, Toshiko |
author_facet | Nakae, Hajime Tomida, Kouki Kikuya, Yoshihiro Okuyama, Manabu Igarashi, Toshiko |
author_sort | Nakae, Hajime |
collection | PubMed |
description | AIM: Human serum albumin (HSA) is known for its multiple functions, such as maintenance of colloid osmotic pressure, transport of endogenous and exogenous substances, and antioxidation. The aim of this study was to measure the redox state and concentrations of β‐d‐glucan and endotoxin to compare the quality of 5% HSA preparations from two different manufacturers. METHODS: The quality of 5% HSA preparations in two different pharmaceutical products (groups A and B) was compared in terms of the percentage of reduced and oxidized albumin and the contaminant level of β‐d‐glucan and endotoxin. RESULTS: The percentage of human mercaptoalbumin in group A was significantly higher than that in group B (P < 0.01), whereas that of human non‐mercaptoalbumin‐2 in group A was significantly lower (P < 0.01). The concentration of β‐d‐glucan in group A was significantly lower than in group B (P < 0.01). CONCLUSIONS: The present findings indicate the need for quality control of HSA preparations in applications involving the use of large volumes. |
format | Online Article Text |
id | pubmed-5674470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56744702017-11-09 Comparison of quality of human serum albumin preparations in two pharmaceutical products Nakae, Hajime Tomida, Kouki Kikuya, Yoshihiro Okuyama, Manabu Igarashi, Toshiko Acute Med Surg Original Articles AIM: Human serum albumin (HSA) is known for its multiple functions, such as maintenance of colloid osmotic pressure, transport of endogenous and exogenous substances, and antioxidation. The aim of this study was to measure the redox state and concentrations of β‐d‐glucan and endotoxin to compare the quality of 5% HSA preparations from two different manufacturers. METHODS: The quality of 5% HSA preparations in two different pharmaceutical products (groups A and B) was compared in terms of the percentage of reduced and oxidized albumin and the contaminant level of β‐d‐glucan and endotoxin. RESULTS: The percentage of human mercaptoalbumin in group A was significantly higher than that in group B (P < 0.01), whereas that of human non‐mercaptoalbumin‐2 in group A was significantly lower (P < 0.01). The concentration of β‐d‐glucan in group A was significantly lower than in group B (P < 0.01). CONCLUSIONS: The present findings indicate the need for quality control of HSA preparations in applications involving the use of large volumes. John Wiley and Sons Inc. 2017-03-01 /pmc/articles/PMC5674470/ /pubmed/29123871 http://dx.doi.org/10.1002/ams2.259 Text en © 2017 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Nakae, Hajime Tomida, Kouki Kikuya, Yoshihiro Okuyama, Manabu Igarashi, Toshiko Comparison of quality of human serum albumin preparations in two pharmaceutical products |
title | Comparison of quality of human serum albumin preparations in two pharmaceutical products |
title_full | Comparison of quality of human serum albumin preparations in two pharmaceutical products |
title_fullStr | Comparison of quality of human serum albumin preparations in two pharmaceutical products |
title_full_unstemmed | Comparison of quality of human serum albumin preparations in two pharmaceutical products |
title_short | Comparison of quality of human serum albumin preparations in two pharmaceutical products |
title_sort | comparison of quality of human serum albumin preparations in two pharmaceutical products |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674470/ https://www.ncbi.nlm.nih.gov/pubmed/29123871 http://dx.doi.org/10.1002/ams2.259 |
work_keys_str_mv | AT nakaehajime comparisonofqualityofhumanserumalbuminpreparationsintwopharmaceuticalproducts AT tomidakouki comparisonofqualityofhumanserumalbuminpreparationsintwopharmaceuticalproducts AT kikuyayoshihiro comparisonofqualityofhumanserumalbuminpreparationsintwopharmaceuticalproducts AT okuyamamanabu comparisonofqualityofhumanserumalbuminpreparationsintwopharmaceuticalproducts AT igarashitoshiko comparisonofqualityofhumanserumalbuminpreparationsintwopharmaceuticalproducts |